Ribosomal proteins (RPs) 
Introduction
Ribosomal proteins (RPs) [1, 2] . The corresponding mRNA of RPS13 was around 30-fold more abundant in the colon cancer cells than in normal colon [1] and about 50-fold more abundant in lung metastasis than in normal lung [2] . Moreover, the expression level of RPS13 correlated well with the growth rate of tumour cells [1] . RPP0 was identified as one differentially expressed gene between human hepatocellular carcinoma and matched non-tumourous liver tissues, which was further confirmed by pathological studies [3] . RPS27 level in hepatocytes increased in regenerating cirrhotic nodules compared to chronic hepatitis and reached the highest level in hepatocellular carcinoma [4] . Up-regulation of RPS2, RPL7a, RPL23a, RPS14 and RPL19 was identified in malignant prostate cancer cell lines and in prostate cancer tissue samples [5] [6] [7] . The [8] . In another study, it was found that RPS3, RPS6, RPS8, RPS12, RPL5 and RPP0 were expressed at higher levels in eight different colon adenocarcinomas and adenomatous polyps [9] . These results suggest that a select pool of RPs might be dysregulated in cancer cells and involved in tumorigenesis. Previously, we analysed the mRNA profiles of a human gastric cancer cell line SGC7901 and its multidrug-resistant variant SGC7901/VCR by differential display PCR and suppression subtractive hybridization [10, 11] . RPS13 was identified as one of the genes overexpressed in SGC7901/VCR comparing to SGC7901, which was further confirmed by RT-PCR and Northern blot analysis [10] . Subsequent [12] . These 
studies revealed that up-regulation of RPS13 could protect gastric cancer cells from vincristine-induced apoptosis and enhance the resistance of gastric cancer cells to multiple chemotherapeutic drugs, including vincristine, adriamycin and 5-fludrouracil

Materials and methods
Tissue collection
DNA constructs and transfection
The cDNA fragment encoding human RPS13 was cloned into pcDNA3.1/V5-His (Invitrogen, Carlsbad, CA, USA) as previously described [12] . (Fig. 3A) , whereas SGC7901/siRPS13 cells grew slower than SGC7901 and SGC7901/siControl cells (Fig. 3B) (Fig. 4B) .
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
Cell cycle analysis
Colony formation assay
Colony formation assay was performed to determine the effects of RPS13 on colony-forming ability of gastric cancer cells. Briefly, a total of 200 cells
Real-time RT-PCR
RPS13 enhanced tumorigenesis of gastric cancer cells
To determine whether elevated RPS13 affected tumorigenesis of gastric cancer, we carried out in vitro colony-forming assay of SGC7901 and its variants. As indicated in Fig. 4A, SGC7901/RPS13 cells showed much more cell colonies than control cells, while SGC7901/siRPS13 cells exhibited much less cell colonies than their control cells. In addition, the anchorage-independent growth of SGC7901 and its variants was also evaluated by soft agar clonogenic assay. It was clear that overexpression of RPS13 induced a significant increase in the colony numbers whereas knocking down of RPS13 resulted in a substantial reduction in colony formation
To further confirm the effects of RPS13 on tumorigenesis of gastric cancer cells, tumour formation assay was performed in nude mice. SGC7901 cell derivates were subcutaneously inoculated into the right upper back of athymic nude mice. Four weeks later, mice were killed and the transplanted tumours were excised (Fig. 5A) and tumour weight was evaluated (Fig. 5B). There was a significant increase of size and weight of xenografts in the presence of RPS13 overexpression. Meanwhile, down-regulation of RPS13 resulted in smaller tumours in nude mice. These data indicated that up-regulation of RPS13 could promote gastric cancer cell growth in vivo and interference of RPS13 expression led to growth suppression.
RPS13 promoted G1/S transition of gastric cancer cells
To address whether RPS13 promoted gastric cancer cell growth through regulating cell cycle progression, cell cycle analysis was performed on SGC7901 and its derivates. Gastric cancer cells at log phase were harvested and analysed for cell cycle phase distribution (Fig. 6A) (Fig. 6C) . Four hours after releasing, the cells began entering into S phase (Fig. 6C) . The average releasing rate of cells from G1 to S phase in SGC7901/RPS13 was 51.3% (Fig. 6C) , which was significantly higher than those of SGC7901/pcDNA3.1 cells (33.2%).
Twelve hours after releasing, most cells had gone into G2 phase. By 16 hrs, cells entered a new cell cycle (Fig. 6C). No significant difference was found in cell cycle profile between SGC7901/pcDNA3.1 and SGC7901/RPS13 cells at 8 hrs and later times after releasing from thymidine block. Taken together, these data strongly indicated that RPS13 played an important role in promoting the growth of gastric cancer cells through accelerating G1 to S phase transition in the cell cycle.
RPS13 down-regulated p27
Kip1 in gastric cancer cells
It is well known that G1-S progression is controlled by cyclinD/CDK4 and cyclinE/CDK2 complexes, which are regulated by INK4 family members and p27
Kip1 , respectively. The expression [19, 20] . In addition, it has been discovered that human RPL13a induces apoptosis, presumably by arresting cell growth in the G2/M phase of the cell cycle [21] . Furthermore, RPS29 was found to induce apoptosis in H520 cells by marginally increasing the release of apoptosis inducing factor and reducing the NF-B dependent transcriptional activity [22] . Similar results have been found in RPL15 and RPS3 [23] .
The present study demonstrated an extra-ribosomal function of RPS13 in gastric cancer. The expression and biological significance of RPS13 in human gastric cancer was firstly investigated. [24] and regulating the eIF4G-dependent translation through direct interactions with PDCD4 in senescent fibroblasts [25] . However, investigations on RPS13-deficient mutant revealed that RPS13 was not essential for cell growth [24] . Our previous work also indicated that overexpression of RPS13 did not alter the protein synthesis rates of gastric cancer cells [12] . Similarly, it was found that inducing exogenous RPS3a expression alone in NIH 3T3 cells did not increase protein synthetic activity [26] . It 
